Skip to main content
. 2024 May 15;25:207. doi: 10.1186/s12931-024-02822-1

Table 2.

Number,mean of exacerbations and number of patients (in parentheses) at each study visit

V1 V2 V3 V4 V5
Statin users (SU) 538 (n = 413) 1.30 332 (n = 366) 0.91 287 (n = 317) 0.91 358 (n = 220) 1.63 144 (n = 152) 0.95
Statin naïve (SN) 1742 (n = 1306) 1.33 1114 (n = 1122) 0.99 995 (n = 946) 1.05 755 (n = 643) 1.17 529 (n = 476) 1.11
Incident-statins (IS) 159 (n = 168) 0.95 167 (n = 165) 1.01 291 (n = 164) 1.77 199 (n = 147) 1.35 167 (n = 118) 1.42

Number of acute exacerbations at each study visit V1-V5

n = number of patients at each visit. The percentages refer to the proportion of exacerbations based on the number of patients